DIABETOGENIC EFFECTS OF HIGH INTENSITY STATIN TREATMENT IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA AND FAMILIAL COMBINED HYPERLIPIDEMIA

被引：0
|
作者：
Liontou, A. A. [1 ]
Pitsavos, C. [1 ]
Skoumas, J. [1 ]
Chrysohoou, C. [1 ]
Masoura, K. [1 ]
Stefanadis, C. [1 ]
机构：
[1] Hippokrateion Hosp, Athens Med Sch, Univ Dept Cardiol 1, Athens, Greece
来源：
ATHEROSCLEROSIS | 2014年 / 235卷 / 02期
关键词：
D O I：
10.1016/j.atherosclerosis.2014.05.137
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EAS-0915
引用
收藏
页码：E56 / E57
页数：2
相关论文
共 50 条
  • [21] Insulin resistance is associated with hypertriglyceridemia and combined hyperlipidemia but not with hypercholesterolemia in familial combined hyperlipidemia
    Pihlajamäki, J
    Karjalainen, L
    Laakso, M
    ATHEROSCLEROSIS, 1999, 144 : 12 - 12
  • [22] The impact of ezetimibe and high-dose of statin treatment on LDL levels in patients with heterozygous familial hypercholesterolemia
    Pitsavos, Christos
    Skoumas, Ioannis
    Tousoulis, Dimitris
    Metalinos, George
    Masoura, Constantina
    Chrysohoou, Christina
    Papadimitriou, Lambros
    Giotsas, Nikolaos
    Toutouza, Marina
    Antoniades, Charalambos
    Stefanadis, Christodoulos
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 134 (02) : 280 - 281
  • [23] COMBINED TREATMENT WITH SIMVASTATIN AND ACIPIMOX IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH ELEVATED LIPOPROTEIN(A)
    MULS, E
    BEX, M
    COBBAERT, C
    VANSANT, G
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 1994, 4 (02) : 78 - 82
  • [24] BILIARY LIPID SECRETION IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA AND COMBINED HYPERLIPIDEMIA - INFLUENCE OF BEZAFIBRATE AND FENOFIBRATE
    LEISS, O
    MEYERKRAHMER, K
    VONBERGMANN, K
    JOURNAL OF LIPID RESEARCH, 1986, 27 (07) : 713 - 723
  • [25] Decreased adiponectin levels and FDG uptake in visceral adipose tissue in familial combined hyperlipidemia compared to heterozygous familial hypercholesterolemia and normolipidemics
    Koutagiar, I.
    Toutouzas, K.
    Antonopoulos, A. S.
    Skoumas, I.
    Oikonomou, E. K.
    Benetos, G.
    Kafouris, P.
    Georgakopoulos, A.
    Miliou, A.
    Galanakos, S.
    Pitsargiotis, T.
    Metaxas, M.
    Pitsavos, C.
    Antoniades, C.
    Tousoulis, D.
    EUROPEAN HEART JOURNAL, 2019, 40 : 336 - 336
  • [26] Disparities in Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia
    Shustak, Rachel
    Perlstein, Abigail
    Artis, Amanda
    Zavez, Alexis
    Tam, Vicky
    Martino, Giordana
    Brothers, Julie
    CIRCULATION, 2024, 150
  • [27] Statin treatment in children with familial hypercholesterolemia in Scandinavia
    Svendsen, K.
    Krogh, H. Walaas
    Bogsrud, M. P.
    Holven, K. B.
    Retterstol, K.
    EUROPEAN HEART JOURNAL, 2019, 40 : 680 - 680
  • [28] FAMILIAL HYPERCHOLESTEROLEMIA AND THE DIABETOGENIC EFFECT OF STATINS
    Zhilina, Svetlana
    Miramontes Gonzalez, Jose Pablo
    Laso Guzman, Francisco Javier
    ATHEROSCLEROSIS, 2017, 263 : E264 - E264
  • [29] Statin restores sympathovagal dysfunction associated with monogenic heterozygous familial hypercholesterolemia
    Santos, MB
    Consolim-Colombo, FM
    Santos, RD
    Chacra, AP
    Martinez, T
    Krieger, EM
    Irigoyen, MC
    Barreto, JAS
    EUROPEAN HEART JOURNAL, 2004, 25 : 38 - 38
  • [30] Dyslipidemia in young Japanese children: its relation to familial hypercholesterolemia and familial combined hyperlipidemia
    Ohta, T
    Kiwaki, K
    Endo, F
    Umehashi, H
    Matsuda, I
    PEDIATRICS INTERNATIONAL, 2002, 44 (06) : 602 - 607
12345